Digital pathology, as a carrier of efficient patient care in the form of long-distance telepathology and telemedecine, can support evolving healthcare needs requiring highly differentiated but integrated products and services. Top causes of inhibited growth is that the costs against the return on investments (ROI) weighs more on the side of costs, while end users’ attitude are no less restrictive. This study predicts that digital pathology will improve in future when new medical applications such as telemedicine as well as new opportunities in the diagnostic services, healthcare IT, and IVD sectors become available.
Key Findings
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
Market Engineering Measurements (continued)
Market Engineering Measurements (continued)
Market Engineering Measurements (continued)
CEO’s Perspective
Executive Summary—Three Big Predictions
Market Background?Overview of Healthcare Situation in China
Market Background?China’s Healthcare System Reforms
Market Background?Hospital System in China
Market Background?China’s Medical Alliances Network
Market Background?Bi-directional Referral System
Emerging Opportunities for Digital Pathology in Telepathology and Telemedicine
Applications of Digital Pathology in China
Applications of Digital Pathology in China Explained
Applications of Digital Pathology in China Explained (continued)
Applications of Digital Pathology in China Explained (continued)
Digital Pathology Workflow Overview
Digital Pathology Workflow Overview (continued)
Overview of Long-distance Telepathology Consultations
China’s Consultation and Quality Control Network Structure
Digital Pathology Market Segmentation
Digital Pathology Hardware Distribution Channel
Digital Pathology Hardware Distribution Channel (continued)
Digital Pathology Systems Segment Overview
Digital Pathology Services Segment Overview
Evolving Digital Pathology Market
Competitive Environment
Key Market Participants
New Market Opportunities
New Market Opportunities (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Mega Trend Impact on Digital Pathology Industry
Market Drivers
Market Drivers Explained
Market Drivers Explained (continued)
Market Drivers Explained (continued)
Market Drivers Explained (continued)
Market Drivers Explained (continued)
Market Restraints
Market Restraints Explained
Market Restraints Explained (continued)
Market Restraints Explained (continued)
Market Restraints Explained (continued)
Market Engineering Measurements
Forecast Assumptions
Total Digital Pathology Market—Revenue Forecast
Total Digital Pathology Market—Revenue Forecast Discussion
Digital Pathology Systems Segment—Key Findings
Digital Pathology Systems Segment—Market Engineering Measurements
Digital Pathology Systems Segment—Market Engineering Measurements (continued)
Digital Pathology Systems Segment—Revenue Forecast
Digital Pathology Systems Segment—Revenue Forecast Discussion
Digital Pathology Services Segment—Key Findings
Digital Pathology Services Segment—Market Engineering Measurements
Digital Pathology Services Segment—Revenue Forecast
Digital Pathology Services Segment—Revenue Forecast Discussion
Digital Pathology Systems Segment Market Overview
Digital Pathology Customers/End-user Segmentation
Digital Pathology Customers/End-user Segmentation (continued)
Digital Pathology Customers/End-user Segmentation (continued)
Companies to Watch
Companies to Watch (continued)
Strategic Options and Recommendations
The Last Word—Three Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
Legal Disclaimer
Frost & Sullivan Reference Material
Decision Support Database?Total Healthcare Expenditure
Decision Support Database?Public Healthcare Expenditure
Decision Support Database?Private Healthcare Expenditure
Decision Support Database?Number of Hospitals
Market Engineering Methodology
Learn More—Next Steps
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Digital pathology, as a carrier of efficient patient care in the form of long-distance telepathology and telemedecine, can support evolving healthcare needs requiring highly differentiated but integrated products and services. Top causes of inhibited growth is that the costs against the return on investments (ROI) weighs more on the side of costs, while end users attitude are no less restrictive. This study predicts that digital pathology will improve in future when new medical applications such as telemedicine as well as new opportunities in the diagnostic services, healthcare IT, and IVD sectors become available.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Raymond Chong |
| Industries | Healthcare |
| WIP Number | P79C-01-00-00-00 |
| Is Prebook | No |
Analysis of the Digital Pathology Market in China
Analysis of the Digital Pathology Market in China
Emerging Healthcare Reforms Fuel Digital Pathology Growth
RELEASE DATE
17-Apr-2014
17-Apr-2014
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: P79C-01-00-00-00
SKU: HC02606-NA-MR_16728
$4,950.00
In stock
SKU
HC02606-NA-MR_16728